Cargando…

Prognostic analysis for Chinese patients with stage I ovarian endometrioid carcinoma

BACKGROUND: This study aimed to identify the clinical and pathological characteristics and the possible prognostic factors for Chinese patients with early-stage ovarian endometrioid carcinoma. METHODS: The present study reviewed the medical records of patients who received initial treatment and a po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yu, Wang, Shu, Qu, Yi-Min, Ji, Yu-Ting, Shen, Keng, Lang, Jing He
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604507/ https://www.ncbi.nlm.nih.gov/pubmed/28923080 http://dx.doi.org/10.1186/s13048-017-0361-0

Ejemplares similares

Endometriosis is the independent prognostic factor for survival in Chinese patients with epithelial ovarian carcinoma
por: Ren, Tong, et al.
Publicado: (2017)

The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas
por: Zhan, Xiangbo, et al.
Publicado: (2019)

Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma
por: Yoneoka, Yutaka, et al.
Publicado: (2018)

Genomic mutation features identify distinct BRCA-associated mutation characteristics in endometrioid carcinoma and endometrioid ovarian carcinoma
por: Cao, Canhui, et al.
Publicado: (2021)

Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry
por: Engqvist, Hanna, et al.
Publicado: (2020)

The Prognostic Value of Retroperitoneal Lymphadenectomy in Apparent Stage IA Endometrial Endometrioid Cancer
por: Liu, Zhao, et al.
Publicado: (2021)

Quantification of recurrence risk based on number of adverse prognostic factors in women with stage I uterine endometrioid carcinoma
por: Cook, Andrew E., et al.
Publicado: (2021)

Preoperative predictive factor analysis of ovarian malignant involvement in premenopausal patients with clinical stage I endometrioid endometrial carcinoma
por: Chen, Qin, et al.
Publicado: (2021)

The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
por: Heinze, Karolin, et al.
Publicado: (2023)

Clinicopathological Prognostic Parameters of Endometrioid Endometrial Carcinomas
por: DROCAŞ, ILEANA, et al.
Publicado: (2022)

Testosterone-Secreting Endometrioid Ovarian Carcinoma Presenting With Hyperandrogenism
por: Rajamani, Krishnakumar, et al.
Publicado: (2022)

Genomic Comparison of Endometrioid Endometrial Carcinoma and Its Precancerous Lesions in Chinese Patients by High-Depth Next Generation Sequencing
por: Wang, Yao, et al.
Publicado: (2019)

Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometrium
por: Pradhan, M., et al.
Publicado: (2012)

Fertility Preserved Hysteroscopic Approach for the Treatment of Stage Ia Endometrioid Carcinoma
por: Wang, Fangfang, et al.
Publicado: (2017)

Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome
por: Hollis, Robert L., et al.
Publicado: (2020)

Myoinvasive Pattern as a Prognostic Marker in Low-Grade, Early-Stage Endometrioid Endometrial Carcinoma
por: Ruz-Caracuel, Ignacio, et al.
Publicado: (2019)

A COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinoma
por: Le Page, Cécile, et al.
Publicado: (2019)

Construction and validation of prognostic nomogram and clinical characteristics for ovarian endometrioid carcinoma: an SEER-based cohort study
por: Ye, Wanlu, et al.
Publicado: (2023)

Fertility-Sparing Treatment in Young Patients With Grade 2 Presumed Stage IA Endometrioid Endometrial Adenocarcinoma
por: Yu, Mei, et al.
Publicado: (2020)

L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial Carcinoma
por: Geels, Yvette P., et al.
Publicado: (2016)

Identification of novel cyclin gene fusion transcripts in endometrioid ovarian carcinomas
por: Agostini, Antonio, et al.
Publicado: (2018)

Integrated molecular characterisation of endometrioid ovarian carcinoma identifies opportunities for stratification
por: Hollis, Robert L., et al.
Publicado: (2021)

Gene Expression Profiles in Stage I Uterine Serous Carcinoma in Comparison to Grade 3 and Grade 1 Stage I Endometrioid Adenocarcinoma
por: Mhawech-Fauceglia, Paulette, et al.
Publicado: (2011)

Ovarian endometrioid carcinoma resembling sex cord-stromal tumor: A case report
por: Wei, Xiao-Xia, et al.
Publicado: (2020)

Pulmonary metastasis of stage I, low-grade endometrioid carcinoma: two case reports and the literature review
por: Wang, Li, et al.
Publicado: (2023)

Prognostic Factors of Early Stage Epithelial Ovarian Carcinoma
por: Hsieh, Shu-Feng, et al.
Publicado: (2019)

Surgical staging of apparent early-stage ovarian mucinous carcinoma
por: Yuan, Zhen, et al.
Publicado: (2022)

Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB
por: Han, Kyung Hee, et al.
Publicado: (2017)

Chemotherapy is not necessary for early-stage serous and endometrioid ovarian cancer after undergoing comprehensive staging surgery
por: Li, Shuqing, et al.
Publicado: (2020)

Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study
por: Zhou, Ling, et al.
Publicado: (2021)

Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma
por: Ruz-Caracuel, Ignacio, et al.
Publicado: (2021)

Survival benefit of radiation in high-risk, early-stage endometrioid carcinoma
por: Xiang, Michael, et al.
Publicado: (2019)

Preoperative thrombocytosis as a prognostic factor in endometrioid-type endometrial carcinoma
por: Abu-Zaid, Ahmed, et al.
Publicado: (2017)

Promoter methylation of IGFBP-3 and p53 expression in ovarian endometrioid carcinoma
por: Torng, Pao-Ling, et al.
Publicado: (2009)

Oncological and Reproductive Outcomes After Fertility-Sparing Surgery for Stage I Mucinous Ovarian Carcinoma
por: Lin, Wei, et al.
Publicado: (2022)

Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas
por: Jamieson, Amy, et al.
Publicado: (2023)

Is Tumor-Free Distance an Independent Prognostic Factor for Early-Stage Endometrioid Endometrial Cancer?
por: Oge, Tufan, et al.
Publicado: (2020)

Mutational Analysis of β‐Catenin Gene in Japanese Ovarian Carcinomas: Frequent Mutations in Endometrioid Carcinomas
por: Sagae, Satoru, et al.
Publicado: (1999)

Myoferlin Expression and Its Correlation with FIGO Histologic Grading in Early-Stage Endometrioid Carcinoma
por: Kim, Min Hye, et al.
Publicado: (2018)

EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers
por: Alldredge, Jill K., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7ob2h7st5b45u7mkeifuoogkrc